This inventor holds 4 USPTO granted patents. Top assignees: Solvay Pharmaceuticals, Gmbh, Solvay Pharmaceuticals, B.v.. Active years: 2006-2008.
Company Filing History:
Years Active: 2006-2008
Title: Guy Nys: Innovator in G-Protein Coupled Receptors
Introduction
Guy Nys is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the study of G-protein coupled receptors. With a total of 4 patents, his work has implications for understanding various biological processes and potential therapeutic applications.
Latest Patents
Guy Nys's latest patents include groundbreaking inventions related to G-protein coupled receptors. One of his patents, titled "Binding assay employing IGS4, a human G-protein coupled neuromedin receptor," focuses on novel polynucleotides and polypeptides. This invention explores the inhibition or activation of these polynucleotides and polypeptides, as well as methods for screening compounds that act as agonists or antagonists. Another significant patent is centered on a "Polynucleotides and expression system of a novel human G-protein coupled receptor," which also delves into the G-protein coupled receptor family, specifically the IGS4-family. Both patents highlight the high affinity binding of neuropeptides known as neuromedin U to the polypeptides involved.
Career Highlights
Throughout his career, Guy Nys has worked with prominent companies in the pharmaceutical industry. He has been associated with Solvay Pharmaceuticals, GmbH and Solvay Pharmaceuticals, B.V. His work in these organizations has contributed to advancements in drug development and biochemistry.
Collaborations
Guy Nys has collaborated with notable professionals in his field, including Willy Deleersnijder and Christiane Löken. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Guy Nys is a distinguished inventor whose work on G-protein coupled receptors has the potential to impact therapeutic strategies significantly. His patents reflect a deep understanding of biochemistry and a commitment to advancing scientific knowledge.